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INSTRUCTIONS TO AUTHORS  
 
The Revista de la OFIL/ Ibero Latin American Journal of Health System Pharmacy, with over 25 
years of experience is a multilingual (Spanish, Portuguese and English) publication that offers a 
forum for researches with professional expertise in all sectors of pharmacy. 
 
It also incorporates the conceptual trends in regulation procedures and legislation, 
organizational models in healthcare, including all advanced in clinical practices. 
 
The journal addresses issues related to hospital pharmacy, community pharmacy, primary care, 
health and social care, training and research, healthcare management and administration and 
all those related to the pharmacy profession. 
 
Authors submitting a paper, do so on the understanding that the work has not been published 
before, is not being considered for publication elsewhere, and has been read and approved by 
all the authors. 
 
Accepted papers become property of the authors and any reproduction partially or in full must 
include the customary bibliographic citation of the Revista de la OFIL/ Ibero Latin American 
Journal of Health System Pharmacy. 
 
The manuscript should be sent to the email address: publicacion@revistadelaofil.org . The 
editor of the journal will acknowledge the receipt of all papers and the inclusion in the editorial 
process will be subsequently notified. 
 
The Editorial Board reserves the right to reject the articles considered not appropriate for 
publication and may also suggest the authors make changes if required. All original manuscripts 
will be peer reviewed anonymously, by specialists appointed by the editors. 
 
SUBMISSION OF MANUSCRIPTS 
 
1. COVER LETTER 
 
The corresponding author is responsible for ensuring in a cover letter that the manuscript 
represents original and unpublished work, except in the form of an abstract and those whose 
work contributed to the paper are acknowledged as contributing author. 
 
2. ETHICAL GUIDELINES 
 
Author who submit a manuscript accept full responsibility for its content as defined by the 
International Committee of Editors of Medical Journals (see www.icmje.org).  
The research submitted to Revista de la OFIL/ Ibero Latin American Journal of Health System 
Pharmacy should be carried out in accordance with internationally accepted recommendations 
for clinical investigation (Declaration of Helsinki, in the recently revised version of the World 
Medical Association; see http://www.wma.net/en/30publications/10policies/b3/index.html ). 
 
2.1 Informed Consent 
 
Authors should include a statement that the patient data were obtained after signed informed 
consent or the reason for lack of consent explained. 
 
 
2.2 Data protection 
 
Data management must comply with relevant privacy protocols, data protection policy and local 
requirements to access medical records. 
 
2.3 Conflict of interest 
 
All contributors are required to fill out the form for disclosure of potential conflict of interest 
(available at: http://www.icmje.org/downloads/coi_disclosure.pdf ). 
 
3. SOURCE OF FUNDING 
 
Authors are required to specify the sources of funding of their research when submitting a 
manuscript.  
 
4. CASE STUDY OF ADVERSE DRUG REACTIONS 
 
In case studies or case series studies of suspected adverse drug reactions (ADRs) authors 
should take into account:  
 
a) There are guidelines for submitting adverse event reports for publication available on: 
http://www.aemps.gob.es/vigilancia/medicamentosUsoHumano/docs/guidelines-
traducidas-2007.pdf (Spanish version), Drug Safety 2007;30(5):367-373 and 
Pharmacoepidemiology and Drug Safety 2007;16:581-587 (English version). 
 
b) ADRs should be reported to the concerned competent authorities via the national 
reporting system, according to national regulations. 
 
c) The following phrase should be included after the case description: “This case has been 
reported to the National Health Authorities”. 
 
 
MANUSCRIPT FORMAT AND STRUCTURE 
 
1) The word processor is Microsoft Word (versions 6.0 or higher) for windows 
a) Times New Roman, 12-point foint size 
b) Double –spaced 
c) Margins: 2,5 cm 
 
2) The languages of publication are Spanish, Portuguese and English. 
 
3) Beginning with the title page, each page should be consecutively numbered. 
 
4) The title page should contain: 
 
a. Title of the paper 
b. Author names 
c. Affiliation of the authors 
d. Corresponding author with complete address, including an email address and 
postal code 
 
 
5) The second page should contain: 
 
a) The abstract (maximum 250 words) in the same language as the article text (Spanish, 
Portuguese and English). It should provide a concise summary of the work and in 
original articles it should describe the objectives, methodology and key results. Papers 
written in Spanish or Portuguese should also submit an abstract in English. Articles in 
English should also include an abstract in Spanish. 
 
b) From 3 to 10 keywords are to be appended to the abstract. Keywords should preferably 
be chosen from the list published by the Medical Subject Headings (MeSH) of the 
National Library of Medicine. Available at: 
http://www.ncbi.nlm.nih.gov/entrez/meshbrowser.cgi. 
Keywords are separated by commas. 
 
6) The third page should contain the title, the abstract and all keywords in the English 
version.  
 
7) The body of the article is presented in the following pages. 
 
 
TYPES OF ARTICLES 
 
The journal publishes five main types of articles: editorials, original researches, review articles, 
special contribution, clinical pharmacy case studies and letters to the Director. 
 
Editorials 
 
Articles about scientific or professional opinions, requested by the Editorial Board to leading 
experts on highly topical subject in pharmacy or related to articles previously published in the 
journal. The number or authors should not exceed 6, maximum 1500 words, one table or figure 
and 10 references. 
 
Original Articles 
 
Original research works with the following structure: abstract and keywords in Spanish or 
Portuguese, abstract and keywords in English, introduction and objectives, material and 
methods, results, discussion and references. 
 
Abstract: The abstract in Spanish or Portuguese and the English version (maximum 250 words), 
should be structure in four sections: introduction and objectives, methods, key results and 
conclusions. Papers in English should include a Spanish version. From 3 to 10 keywords are to 
be appended to the abstract. Keywords should preferably be chosen from the list published by 
the Medical Subject Headings (MeSH) of the National Library of Medicine. Available at: 
http://www.ncbi.nlm.nih.gov/entrez/meshbrowser.cgi. 
Keywords are separated by commas. 
 
Text: The text is limited to 3000 words, a maximum of 10 tables or figures (total) and 30 
references. The number or authors should not exceed 6. 
 
Review articles: 
 
These articles are an objective and critical analysis of the relevant available research and non-
research literature on the topic being studied. The maximum word-length is 3000 words and 15 
tables or figures (total). The number or authors should not exceed 6. References are not limited. 
 
Special articles 
 
This section includes articles on topics of particular interest or relevance that do not fit into any 
of the other categories and requested by the Editorial Board. Authors should contact the 
Director of the journal if not requested. 
 
Clinical Pharmacy Case Study 
 
Descriptive research of one or more clinical cases in which pharmacists are involved. The text is 
limited to 1500 words, a maximum of 2 tables or figures and 10 references. The number or 
authors should not exceed 4. 
 
Letter to the Director 
 
This section includes comments related to works recently published in the journal. The 
maximum word-length is 1000 words, no more than 1 table or figure and 8 references. The 
number or authors should not exceed 4. 
 
 
REFERENCES 
 
The references list appears at the end of the text enumerated consecutively in the order in 
which they are first mentioned in the text by numbers in superscript. Only references that 
contribute substantially to the subject of the study should be enumerated to avoid exhaustive 
lists (with the exception of the Reviews). Journal titles should be abbreviated according to the 
Index Medicus available at http://www.nlm.nih.gov. The style for references is based on the 
reccomendation of the International Committee of Medical Journal Editors (ICMJE) available at 
http://www.nlm.nih.gov/bsd/uniform_requirements.html  
Sample references typically used by authors of journal articles are provided below. 
 
1. Articles in journals 
 
List the first six authors, when there are more than six, only the firs six followed by the 
expression “et al” should be cited. 
 
Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of 
interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 
2002;935(2):40-6. 
2. Organization as author 
 
Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in 
participants with impaired glucose tolerance. Hypertension. 2002;40(5):679-86. 
3. Volume with supplement 
 
Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-
term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 
Suppl 2:S93-9. 
4. Books and other monographs 
 
Personal author(s) 
Jiménez Murillo L, Montero Pérez FJ. Clinical Medicin. 2ª ed. Madrid: Elsevier; 2005. 
Author(s) and Editor(s) 
 
Norman IJ, Redfern SJ, editores. Mental health care for elderly people. Nueva York: Churchill 
Livingston; 1996. 
Chapter in a book 
 
Phillips SJ, Whisnant JP. Hypertension and stroke. En: Laragh JH, Brenner BM, editores. 
Hypertension: pathophysiology, diagnosis, and management. 2.a ed. Nueva York: Raven Press; 
1995. p. 465-78. 
5. Conference paper 
 
Publications in a journal of abstracts are cited as an article. If it is published in an abstract book 
are cited as a chapter in a book. 
 
6. Scientific or technical report 
 
Yen GG (Oklahoma State University, School of Electrical and Computer Engineering, Stillwater, 
OK). Health monitoring on vibration signatures. Final report. Arlington (VA): Air Force Office of 
Scientific Research (US), Air Force Research Laboratory; 2002 Feb. Report No.: 
AFRLSRBLTR020123. Contract No.: F496209810049.  
 
7. Dissertation 
 
Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans 
[dissertation]. Mount Pleasant (MI): Central Michigan University; 2002.  
 
8. Legal material 
 
• Veterans Hearing Loss Compensation Act of 2002, Pub. L. No. 107-9, 115 Stat. 11 
(May 24, 2001). 
 
• Official Journal of the European Union. Directive 2001/83/EC on the Community code 
relating to medicinal products for human use. OJEU No L 348, 31.12.2010. 
 
9. Newspaper articles 
 
Lee G. Hospitalizations tied to ozone pollution: study estimates 50,000 admissions annually. 
The Washington Post. 1996 Jun 21;Sect. A:3 (col. 5). 
 
10. In press or forthcoming 
 
Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature of balancing selection in 
Arabidopsis. Proc Natl Acad Sci USA. In press 2002. 
 
11. Electronic material 
 
Electronic journal article 
 
Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis.1995;1(1). [cited 
1996 july 9].  Available from: http://www. cdc.gov/ncidod/ EID/eid.htm. 
 
Article published on the Internet ahead of the print version 
 
Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. 
Blood. 2002 Nov 15;100(10):3828-31. Epub 2002 Jul 5. 
 
Monograph on the Internet 
 
Foley KM, Gelband H, editors. Improving palliative care for cancer [Internet]. Washington: 
National Academy Press; 2001 [cited 2002 Jul 9]. Available from: 
http://www.nap.edu/books/0309074029/html/. 
 
Homepage/Web site 
 
American Medical Association [Internet]. Chicago: The Association; c1995-2002 [cited 2002 
Aug 12]. AMA Office of Group Practice Liaison. Available from: http://www.ama-
assn.org/ama/pub/category/1736.html. 
 
Database on the Internet 
 
Who's Certified [Database on the Internet]. Evanston (IL): The American Board of Medical 
Specialists.  [cited 2001 march 8]. Avaliable from: http://www.abms.org/newsearch.asp 
 
 
TABLES 
 
Arabic numerals are used to number the tables in the order of their appearance in the text. Each 
table is presented on a separate sheet. The title appears at the top and abbreviations in 
alphabetical order at the bottom. The content is self explanatory and information is not repeated 
in the text or in figures. 
 
FIGURES 
 
Figures are designated by Arabic numerals ordered as they appear in the text. Each figure is 
presented on a separate sheet. Line drawing or graphs should preferably be sent in JPG format 
with a high quality and resolution. Figure legends are provided on a separate sheet. At the end 
of each legend, abbreviations are identified in alphabetical order. Figures include no information 
that would allow a patient or hospital to be identified. Patient photographs must be taken in a 
way that ensures anonymity, or the consent of that patient must also consent. 
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REPORTING GUIDELINES FOR SPECIFIC STUDY DESIGNS 
 
The Revista de la OFIL/ Ibero Latin American Journal of Health System Pharmacy in an attempt 
to ensure the quality and transparency of published research, recommends that authors and 
reviewers adhere to the reporting guidelines of the EQUATOR network (http://www.equator-
network.org/): 
  
• STROBE for reporting observational studies (cohort, case-control, cross-sectional). 
• CONSORT for reporting randomized trials. 
• PRISMA for reporting systematic reviews and meta-analyses 
• CARE for clinical case reports. 
• STARD for reporting of diagnostic accuracy. 
• CHEERS for economic evaluations of health interventions 
